Comparison of direct cortical stimulation and transcranial magnetic stimulation in brain tumor surgery: systematic review and meta analyses

1

Brain tumors are rare but cause significant mortality, with nearly 251,329 deaths annually and low survival rates of 36.2% at 2 years.
2

Direct cortical stimulation (DCS) is the gold standard for mapping eloquent brain areas during tumor surgery, despite its invasive nature.
3

Transcranial magnetic stimulation (TMS) offers a non-invasive alternative for eloquent area mapping, potentially with comparable efficacy to DCS.
4

This systematic review aims to compare clinical outcomes and adverse events between DCS and TMS in brain tumor patients.
5

Fourteen eligible studies from 2010 to 2023 were identified for meta-analysis, highlighting the need for more randomized studies in this field.

Journal Of Neuro-Oncology

by Rr. Suzy Indharty, Iskandar Japardi, Rr. Sinta Irina, Steven Tandean, Andre Marolop Pangihutan Siahaan, Michael Lumintang Loe, Alvin Ivander
July 12, 2023

1